Metropolis Healthcare has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO). The IPO is of up to 1,52,69,684 equity shares, consisting an offer for sale of up to 50,17,868 equity shares by Sushil Kanubhai Shah and up to 1,02,51,816 equity shares by CA Lotus Investments.
The objects of the offer are to achieve the benefits of listing the equity shares on the stock exchanges and for the offer for sale. The book running lead managers to the issue are JM Financial, Credit Suisse Securities (India), Goldman Sachs (India), HDFC Bank and Kotak Mahindra Capital Company. The company’s shares are proposed to be listed on the BSE and NSE.
Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8094.85 |
| Max Healthcare Inst | 1012.35 |
| Narayana Hrudayalay | 1819.75 |
| Aster DM Healthcare | 742.40 |
| Global Health | 1200.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: